Koljonen Virve, Böhling Tom, Haglund Caj, Ristimäki Ari
Department of Plastic Surgery, Helsinki University Hospital, Helsinki, Finland.
J Cutan Pathol. 2008 Jan;35(1):10-4. doi: 10.1111/j.1600-0560.2007.00762.x.
HuR is a ubiquitously expressed member of the Elav/Hu family of mRNA-binding proteins, and its cytoplasmic expression has been recognised to participate in carcinogenesis. The aims of this study were to explore the expression pattern of HuR in primary Merkel cell carcinoma (MCC), lymph node metastases and non-neoplastic skin.
Twenty-two primary MCC samples and five lymph node metastases were evaluated for HuR expression by immunohistochemistry. The data were compared with clinical parameters.
Nuclear and cytoplasmic HuR-staining patterns were observed. Nuclear immunoreactivity was observed in 91% of the primary tumors and in 80% of the lymph node metastases. Cytoplasm was positive in 27% of the primary tumors and in 60% of the lymph node metastases. No cytoplasmic HuR immunoreactivity was detected in non-neoplastic skin. However, moderate to strong nuclear staining was found in normal epidermis and in the epithelium of hair follicles and sebaceous glands. Expression of HuR in MCC did not associate with clinicopathological parameters.
Primary MCCs and their lymph node metastases as well as non-neoplastic skin show nuclear expression of HuR protein. In contrast to non-neoplastic skin, a subset of MCC tumors show cytoplasmic HuR staining, which may contribute to carcinogenesis in MCC.
HuR是一种在mRNA结合蛋白的Elav/Hu家族中广泛表达的成员,其在细胞质中的表达已被认为参与致癌过程。本研究的目的是探讨HuR在原发性默克尔细胞癌(MCC)、淋巴结转移灶和非肿瘤性皮肤中的表达模式。
通过免疫组织化学评估22例原发性MCC样本和5例淋巴结转移灶中的HuR表达。将数据与临床参数进行比较。
观察到核和细胞质HuR染色模式。在91%的原发性肿瘤和80%的淋巴结转移灶中观察到核免疫反应性。27%的原发性肿瘤和60%的淋巴结转移灶中细胞质呈阳性。在非肿瘤性皮肤中未检测到细胞质HuR免疫反应性。然而,在正常表皮以及毛囊和皮脂腺上皮中发现中度至强的核染色。HuR在MCC中的表达与临床病理参数无关。
原发性MCC及其淋巴结转移灶以及非肿瘤性皮肤均显示HuR蛋白的核表达。与非肿瘤性皮肤不同,一部分MCC肿瘤显示细胞质HuR染色,这可能有助于MCC的致癌作用。